Published in Clin Chim Acta on October 31, 1991
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest (1977) 3.96
Biochemistry of peroxisomes. Annu Rev Biochem (1992) 3.51
Inorganic and organic phosphate measurements in the nanomolar range. Anal Biochem (1987) 3.24
Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet (2001) 3.05
Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J Biol Chem (1979) 2.66
A unified nomenclature for peroxisome biogenesis factors. J Cell Biol (1996) 2.25
Peroxisomal disorders: a newly recognised group of genetic diseases. Eur J Pediatr (1986) 2.05
Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci U S A (1987) 1.98
Cystathionine beta-synthase mutations in homocystinuria. Hum Mutat (1999) 1.96
Peroxisomal lipid metabolism. Annu Rev Nutr (1994) 1.93
Characteristics of fatty acid oxidation in rat liver homogenates and the inhibitory effect of malonyl-CoA. Biochim Biophys Acta (1978) 1.78
Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome. Biochem Biophys Res Commun (1984) 1.77
The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae. EMBO J (1996) 1.72
Control of gluconeogenesis in rat liver cells. Flux control coefficients of the enzymes in the gluconeogenic pathway in the absence and presence of glucagon. Biochem J (1986) 1.70
Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. J Clin Invest (1988) 1.68
Recurrent abdominal pain in children: psychiatric diagnoses and parental psychopathology. J Am Acad Child Adolesc Psychiatry (1990) 1.64
Permeability of the peroxisomal membrane to cofactors of beta-oxidation. Evidence for the presence of a pore-forming protein. J Biol Chem (1987) 1.62
A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet (1988) 1.59
Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet (2001) 1.56
Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene. Acta Paediatr (2004) 1.55
Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans (2001) 1.52
Analysis of the carboxyl-terminal peroxisomal targeting signal 1 in a homologous context in Saccharomyces cerevisiae. J Biol Chem (1996) 1.52
Identification and characterization of the putative human peroxisomal C-terminal targeting signal import receptor. J Biol Chem (1995) 1.51
Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder. J Inherit Metab Dis (1992) 1.50
Rhizomelic chondrodysplasia punctata with isolated DHAP-AT deficiency. Arch Dis Child (1993) 1.47
Peroxisomal and mitochondrial carnitine acetyltransferases of Saccharomyces cerevisiae are encoded by a single gene. EMBO J (1995) 1.47
A mouse model for Zellweger syndrome. Nat Genet (1997) 1.43
Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun (1992) 1.42
The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J Biol Chem (1994) 1.41
Delay in diagnosis of X-linked adrenoleukodystrophy. Clin Neurol Neurosurg (1993) 1.40
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy. Nutrition (2001) 1.40
Monoamine neurotransmitters and metabolites in the cerebrospinal fluid following perinatal asphyxia. Biol Neonate (1995) 1.39
Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange. Hum Mutat (2001) 1.38
Magneto infrared absorption in high electron density GaAs quantum wells. Phys Rev Lett (2001) 1.38
Peroxisomal disorders: a review. J Neuropathol Exp Neurol (1995) 1.37
Peroxisomal disorders in neurology. J Neurol Sci (1988) 1.36
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis (2005) 1.36
Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature (1983) 1.35
Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome. Proc Natl Acad Sci U S A (1996) 1.35
Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet (1993) 1.34
Biosynthesis and maturation of peroxisomal beta-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci U S A (1986) 1.31
Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol (2001) 1.31
Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J Inherit Metab Dis (1995) 1.31
Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals. Cell Biochem Biophys (2000) 1.30
Substrate specificities of rat liver peroxisomal acyl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J Biol Chem (1992) 1.29
Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet (2001) 1.29
Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome. Biochem Biophys Res Commun (1984) 1.28
Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome. Biochem Biophys Res Commun (1985) 1.28
Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet (2001) 1.28
Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res (1988) 1.27
Socialization of children's emotion regulation in mother-child dyads: a developmental psychopathology perspective. Dev Psychopathol (2001) 1.26
Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver. J Biol Chem (1991) 1.26
2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism. Pediatr Res (2000) 1.25
Human pex19p binds peroxisomal integral membrane proteins at regions distinct from their sorting sequences. Mol Cell Biol (2001) 1.24
New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J (2000) 1.22
Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM. J Inherit Metab Dis (2008) 1.22
Genetic defects of cytochrome c oxidase assembly. Physiol Res (2004) 1.20
Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology (1993) 1.20
Acyl-CoA:dihydroxyacetone phosphate acyltransferase in human skin fibroblasts: study of its properties using a new assay method. Biochim Biophys Acta (1986) 1.20
Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1). Biochim Biophys Acta (2000) 1.19
Beta-ketothiolase deficiency in a family confirmed by in vitro enzymatic assays in fibroblasts. Eur J Pediatr (1982) 1.19
Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system. Eur J Biochem (1997) 1.19
Identification and purification of a peroxisomal branched chain fatty acyl-CoA oxidase. J Biol Chem (1991) 1.18
Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells. Hum Mol Genet (1993) 1.17
Rat liver dihydroxyacetone-phosphate acyltransferases and their contribution to glycerolipid synthesis. J Biol Chem (1984) 1.17
L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol (1992) 1.16
Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses. Mol Genet Metab (2001) 1.14
Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts. Eur J Cell Biol (1989) 1.13
Biochemical studies in the liver and muscle of patients with Zellweger syndrome. Pediatr Res (1983) 1.13
X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J Inherit Metab Dis (1996) 1.13
Postnatal diagnosis of peroxisomal disorders: a biochemical approach. Biochimie (1993) 1.13
Presence of three acyl-CoA oxidases in rat liver peroxisomes. An inducible fatty acyl-CoA oxidase, a noninducible fatty acyl-CoA oxidase, and a noninducible trihydroxycoprostanoyl-CoA oxidase. J Biol Chem (1990) 1.11
Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine beta-synthase using an improved bacterial expression system. Hum Mol Genet (1994) 1.11
Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic side of the peroxisomal membrane. Biochem J (1982) 1.11
Sphingosine-phosphate lyase. Adv Lipid Res (1993) 1.10
Large-scale purification and further characterization of rat pristanoyl-CoA oxidase. Eur J Biochem (1994) 1.09
Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) syndrome and related disorders. Biochem Biophys Res Commun (1988) 1.08
Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J Biol Chem (2000) 1.07
Lysosomal triacylglycerol lipase and lipolysis in isolated rat hepatocytes. J Biol Chem (1979) 1.07
Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem (2001) 1.07
Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics (1992) 1.07
Properties of carbamoyl-phosphate synthetase (ammonia) in rat-liver mitochondria made permeable with toluene. Eur J Biochem (1983) 1.06
Iodixanol (Optiprep), an improved density gradient medium for the iso-osmotic isolation of rat liver peroxisomes. Anal Biochem (1996) 1.06
Conversion of dihydroceramide into ceramide: involvement of a desaturase. Biochem J (1997) 1.06
Rhizomelic chondrodysplasia punctata: another peroxisomal disorder. N Engl J Med (1985) 1.05
Emotion management skills in sexually maltreated and nonmaltreated girls: a developmental psychopathology perspective. Dev Psychopathol (2000) 1.05
Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection (2005) 1.05
Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochem Biophys Res Commun (1988) 1.04
Role of glycerol 3-phosphate and glycerophosphate acyltransferase in the nutritional control of hepatic triacylglycerol synthesis. Biochem J (1982) 1.03
Profiling of amino acids in body fluids and tissues by means of liquid chromatography. J Chromatogr (1986) 1.02
Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder. J Inherit Metab Dis (1994) 1.02